ArticleCancer chemotherapy and pharmacology2021

FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 *28 and *6 polymorphism: a multicenter, retrospective study.

Kumiko Umemoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.